Research - Health Care - Harvard Business School

18 Sep 2019
Working Paper Summaries

Female Inventors and Inventions

by Rembrand Koning, Sampsa Samila, and John-Paul Ferguson

                          Does the gender of inventors make a difference for who benefits from their inventions? Analysis of all U.S. biomedical patents issued between 1976 and 2010 shows that research teams with women were more likely to produce patents addressing women’s health conditions,...

Article

Hospital Adoption of API-enabled Patient Data Access

By: A Jay Holmgren and Nate C. Apathy

11 Sep 2019
News

Germany May Have the Answer for Reducing Drug Prices

Re: Ariel Dora Stern

                          In Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Ariel Dora Stern asks whether "value-based pricing" should become the standard elsewhere.

10 Sep 2019
News

New Survey Shows U.S. Businesses Taking Steps to Foster Culture Of Health, But Room to Grow

Re: Robert Huckman

                          BOSTON—In a new article published today in The Milbank Quarterly, a multidisciplinary journal of population health and health policy, researchers from Harvard Business School (HBS) and Harvard T.H. Chan School of Public Health, discuss the results of a recently...

Article

Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study

By: Maryaline Catillon

Fall 2019
Article

Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals

By: Kyle Myers and Mark Pauly

We examine trends in the productivity of the pharmaceutical sector over the past three decades. Motivated by Ricardo’s insight that productivity and rents are endogenous to demand when inputs are scarce, we examine the industry’s aggregate R&D production function....

Forthcoming
Article

Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

By: Derek C. Angus, Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc J. M. Bonten, Mary Brophy, Christopher Butler, Timothy F. Cloughesy, Lennie P. G. Derde, Laura J. Esserman, Ryan Ferguson, Louis Fiore, Sarah C. Gaffey, J. Michael Gaziano, Kathy Giusti, Herman Goossens, Stephane Heritier, Bradley Hyman, Michael Krams, Kay Larholt, Lisa M. LaVange, Philip Lavori, Andrew W. Lo, Alexander J. London, Victoria Manax, Colin McArthur, Genevieve O’Neill, Giovanni Parmigiani, Jane Perlmutter, Elizabeth A. Petzold, Craig Ritchie, Kathryn M. Rowan, Christopher W. Seymour, Nathan I. Shapiro, Diane M. Simeone, Bradley Smith, Bradley Spellberg, Ariel Dora Stern, Lorenzo Trippa, Mark Trusheim, Kert Viele, Patrick Y. Wen and Janet Woodcock

Researchers, clinicians, policymakers, and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to answer with traditional, free-standing, parallel-group randomized controlled trials (RCTs). Examples include...

28 Aug 2019
Working Paper Summaries

Who Drives Digital Innovation? Evidence from the US Medical Device Industry

by Cirrus Foroughi and Ariel Dora Stern

                          Major industries are undergoing a digital transformation, in which key aspects of new product development are migrating to a software-driven context. In the medical device industry, experience matters, as does the geographic clustering of new product development, which...

2019
Working Paper

Improving Regulatory Effectiveness Through Better Targeting: Evidence from OSHA

By: Matthew S. Johnson, David I. Levine and Michael W. Toffel

We study how a regulator can best allocate its limited inspection resources. We direct our analysis to a U.S. Occupational Safety and Health Administration (OSHA) inspection program that targeted dangerous establishments and allocated some inspections via random...

Forthcoming
Article

The Elasticity of Science

By: Kyle Myers

This paper identifies the degree to which scientists are willing to change the direction of their work in exchange for resources. Data from the National Institutes of Health are used to estimate how scientists respond to targeted funding opportunities. Inducing a...

Forthcoming
Article

Making medications stick: improving medication adherence by highlighting the personal health costs of non-compliance

By: Jon M. Jachimowicz, Joe J. Gladstone, Dan Berry, Charlotte L. Kirkdale, Tracey Thornley and Adam D. Galinsky

Poor compliance of prescription medication is an ongoing public health crisis. Nearly half of patients do not take their medication as prescribed, harming their own health while also increasing public health care costs. Despite these detrimental consequences, prior...

14 Aug 2019
News

Pasricha on the Perils of Retirement

                      
                          In a recent interview with WBUR, author Neil Pasricha (MBA 2007) argues that retirement “is a terrible idea.” Inspired by anecdotal examples of people whose health failed shortly after retirement, Pasricha—author of the bestselling book The Happiness Equation—began to...